MR3

synthetic nanobody against SARS-CoV-2

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Link	Tested on	Impact factor	Notes	Publication date
Potent synthetic nanobodies against SARS-CoV-2 and molecular basis for neutralization Preprint	in vitro			Jun/10/2020

Link	Publication date
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection	Jun/18/2021